TCT Group Content Manager Sam Davies speaks to the University of Nottingham about the development of a 3D printing toolkit for the design of healthcare applications.
Materialise has announced the opening of a new medical 3D printing facility in the United States, which the company says will accelerate the delivery of patient-specific medical implants to patients in the country.
Boston Micro Fabrication (BMF) has announced it is entering the dental market with the launch of UltraThineer, the world’s thinnest cosmetic dental veneer according to the company, developed in collaboration with Peking University.
3D Systems and Theradaptive, a biopharmaceutical company specialising in targeted regenerative therapeutics, have announced that they have entered a commercial agreement naming 3D Systems as Theradaptive’s exclusive 3D printing partner.
Lightforce Orthodontics has announced the raising of 80 million USD in its Series D funding round, which will be used to build a new manufacturing facility and grow the company's engineering team.
Axial3D has announced that it has received FDA clearance for an automated, AI-driven, cloud-based segmentation platform for orthopaedic trauma, orthopaedic, maxillofacial, and cardiovascular applications.
Desktop Health, a brand of Desktop Metal, has announced that it has partnered with Carbon to validate Flexcera Smile Ultra+ for use on the Carbon Digital Manufacturing Platform.
Shapeways has announced two ‘significant’ contracts in the medical space that it expects to generate up to 2.5 million USD in revenue each year for the next three years.
Desktop Health, the medical 3D printing arm of Desktop Metal, has announced the launch of PrintRoll, a rotating build platform that can produce intelligent tubular solutions for the body’s vascular, digestive, respiratory and reproductive channels.
Lithoz has announced a long-term partnership with New York-based biomaterials specialist Himed, as the companies join forces to accelerate innovation and research into the 3D printing of medical-grade bioceramics.
3D printed medical device firm restor3d has entered into a definitive merger agreement which will see it acquire all outstanding shares of common stock of Conformis.
The biotech company behind the 3D printed ‘lab-on-a-chip’ platforms, is accelerating the development and manufacture of cheaper drugs and vaccines, after an Innovate UK-backed project.
